[
  {
    "title": "派林生物(000403.SZ)截至12月底已累计回购98.8501万股",
    "href": "http://stock.jrj.com.cn/2023/01/06191437265186.shtml",
    "datetime": "2023-01-06 19:14:25",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康减持期届满 已减持437.4603万股",
    "href": "http://stock.jrj.com.cn/2022/12/28200737244212.shtml",
    "datetime": "2022-12-28 20:07:35",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：杨峰及一致行动人大宗交易减持0.76%股份",
    "href": "http://stock.jrj.com.cn/2022/12/14184837212762.shtml",
    "datetime": "2022-12-14 18:48:53",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：拟变更审计机构",
    "href": "http://stock.jrj.com.cn/2022/11/30205537179484.shtml",
    "datetime": "2022-11-30 20:55:49",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：子公司拟出资设立基金管理人",
    "href": "http://stock.jrj.com.cn/2022/11/30205337179487.shtml",
    "datetime": "2022-11-30 20:53:49",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：截至11月底已累计回购98.85万股",
    "href": "http://stock.jrj.com.cn/2022/11/30201637179337.shtml",
    "datetime": "2022-11-30 20:16:06",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：控股股东解质785万股",
    "href": "http://stock.jrj.com.cn/2022/11/16193937144604.shtml",
    "datetime": "2022-11-16 19:39:33",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：尚志浆站获得单采血浆许可证",
    "href": "http://stock.jrj.com.cn/2022/11/10184937128542.shtml",
    "datetime": "2022-11-10 18:49:31",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)截至10月底已累计回购98.85万股",
    "href": "http://stock.jrj.com.cn/2022/11/01202137104540.shtml",
    "datetime": "2022-11-01 20:21:04",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)截至9月底已累计回购87.23万股",
    "href": "http://stock.jrj.com.cn/2022/10/10220737045374.shtml",
    "datetime": "2022-10-10 22:07:10",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康减持期过半 累计减持287.46万股",
    "href": "http://stock.jrj.com.cn/2022/09/29173237031456.shtml",
    "datetime": "2022-09-29 17:32:45",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：子公司取得两化融合管理体系评定证书",
    "href": "http://stock.jrj.com.cn/2022/09/08183336983978.shtml",
    "datetime": "2022-09-08 18:33:03",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)8月31日首次回购45万股",
    "href": "http://stock.jrj.com.cn/2022/08/31180536958915.shtml",
    "datetime": "2022-08-31 18:05:16",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：铁力浆站获得单采血浆许可证",
    "href": "http://stock.jrj.com.cn/2022/08/29214336949352.shtml",
    "datetime": "2022-08-29 21:43:50",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：尚未回购股份",
    "href": "http://stock.jrj.com.cn/2022/08/11171936891123.shtml",
    "datetime": "2022-08-11 17:19:33",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：17.3767万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2022/07/12220236805027.shtml",
    "datetime": "2022-07-12 22:02:06",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：76.7965万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2022/07/12220136805030.shtml",
    "datetime": "2022-07-12 22:01:02",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：2021年度利润分配10派0.56元 股权登记日7月14日",
    "href": "http://stock.jrj.com.cn/2022/07/08194036795636.shtml",
    "datetime": "2022-07-08 19:40:39",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：已收到业绩承诺方全额支付的业绩补偿款5994.68万元",
    "href": "http://stock.jrj.com.cn/2022/07/07211336792282.shtml",
    "datetime": "2022-07-07 21:13:02",
    "code": "000403"
  },
  {
    "title": "派林生物将花不超8000万元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2022/07/05221036785098.shtml",
    "datetime": "2022-07-05 22:10:56",
    "code": "000403"
  },
  {
    "title": "派林生物等拟回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/04074336778400.shtml",
    "datetime": "2022-07-04 07:43:32",
    "code": "000403"
  },
  {
    "title": "派林生物将花不超8000万元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2022/07/01221036776728.shtml",
    "datetime": "2022-07-01 22:10:29",
    "code": "000403"
  },
  {
    "title": "派林生物：拟4000万元至8000万元回购股份",
    "href": "http://stock.jrj.com.cn/2022/07/01203036776471.shtml",
    "datetime": "2022-07-01 20:30:31",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：拟以4000万-8000万元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/07/01195436776385.shtml",
    "datetime": "2022-07-01 19:54:47",
    "code": "000403"
  },
  {
    "title": "【龙虎榜】派林生物6月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/06/22180336750292.shtml",
    "datetime": "2022-06-22 18:03:22",
    "code": "000403"
  },
  {
    "title": "大股东清仓与业绩无关 派林生物正开拓海外血制品市场",
    "href": "http://stock.jrj.com.cn/2022/06/07091136708249.shtml",
    "datetime": "2022-06-07 09:11:00",
    "code": "000403"
  },
  {
    "title": "派林生物股东航运健康减持2312.54万股 套现6.15亿 2021年公司净利3.91亿",
    "href": "http://stock.jrj.com.cn/2022/06/06215236707232.shtml",
    "datetime": "2022-06-06 21:52:06",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：减持期届满 航运健康已减持3.1550%股份",
    "href": "http://stock.jrj.com.cn/2022/06/06193336706775.shtml",
    "datetime": "2022-06-06 19:33:41",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康拟减持不超5.2651%的股份",
    "href": "http://stock.jrj.com.cn/2022/06/05172836703681.shtml",
    "datetime": "2022-06-05 17:28:24",
    "code": "000403"
  },
  {
    "title": "派林生物2021年净利3.91亿同比增长110.29% 董事长付绍兰薪酬370.25万",
    "href": "http://stock.jrj.com.cn/2022/05/04175036557831.shtml",
    "datetime": "2022-05-04 17:50:53",
    "code": "000403"
  },
  {
    "title": "派林生物2021年净利3.91亿同比增长110.27% 产品种类同比增多",
    "href": "http://stock.jrj.com.cn/2022/04/16125236351892.shtml",
    "datetime": "2022-04-16 12:52:07",
    "code": "000403"
  },
  {
    "title": "派林生物2022年第一季度预计净利9588万-1.24亿 同比增加70%-120% 原料血浆采集增长",
    "href": "http://stock.jrj.com.cn/2022/04/15213036347412.shtml",
    "datetime": "2022-04-15 21:30:50",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)一季度净利润预增70%-120%",
    "href": "http://stock.jrj.com.cn/2022/04/15184936346116.shtml",
    "datetime": "2022-04-15 18:49:58",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)业绩快报：2021年度净利升110.27%至3.91亿元",
    "href": "http://stock.jrj.com.cn/2022/04/15184936346120.shtml",
    "datetime": "2022-04-15 18:49:29",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康所持公司股份被司法冻结1276.2454万股",
    "href": "http://stock.jrj.com.cn/2022/04/08173436273095.shtml",
    "datetime": "2022-04-08 17:34:51",
    "code": "000403"
  },
  {
    "title": "派林生物二股东和曹升、陈浩等7人因违规减持被处罚 被记入证券期货市场诚信档案",
    "href": "http://stock.jrj.com.cn/2022/03/29101036079586.shtml",
    "datetime": "2022-03-29 10:10:36",
    "code": "000403"
  },
  {
    "title": "派林生物总经理黄灵谋辞职 2020年薪酬为286.78万",
    "href": "http://stock.jrj.com.cn/2022/03/14201334825665.shtml",
    "datetime": "2022-03-14 20:13:45",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)聘任袁华刚为总经理",
    "href": "http://stock.jrj.com.cn/2022/03/14180834824946.shtml",
    "datetime": "2022-03-14 18:08:08",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：总经理黄灵谋辞职 继续担任董事职务",
    "href": "http://stock.jrj.com.cn/2022/03/14180534824907.shtml",
    "datetime": "2022-03-14 18:05:53",
    "code": "000403"
  },
  {
    "title": "派林生物部分董监高增持25.98万股 耗资716.95万 2021年公司净利4.02亿-4.84亿",
    "href": "http://stock.jrj.com.cn/2022/03/11201434815518.shtml",
    "datetime": "2022-03-11 20:14:48",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：增持期届满 部分董监高及核心员工已合计增持25.98万股",
    "href": "http://stock.jrj.com.cn/2022/03/11172634814522.shtml",
    "datetime": "2022-03-11 17:26:02",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解除质押400万股",
    "href": "http://stock.jrj.com.cn/2022/03/03193334517081.shtml",
    "datetime": "2022-03-03 19:33:18",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：拟继续使用不超6亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/03/03193134517071.shtml",
    "datetime": "2022-03-03 19:31:24",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：拟继续使用部分闲置募集资金不超2.5亿元暂补流动资金",
    "href": "http://stock.jrj.com.cn/2022/03/03192934517046.shtml",
    "datetime": "2022-03-03 19:29:52",
    "code": "000403"
  },
  {
    "title": "派林生物股东同智成科技质押2000万股 用于融资",
    "href": "http://stock.jrj.com.cn/2022/02/24221334453521.shtml",
    "datetime": "2022-02-24 22:13:07",
    "code": "000403"
  },
  {
    "title": "派林生物2021年预计净利4.02亿-4.84亿同比增长116%-160% 销售利润明显提升",
    "href": "http://stock.jrj.com.cn/2022/01/28183134243794.shtml",
    "datetime": "2022-01-28 18:31:56",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：2021年度净利预增116%-160%",
    "href": "http://stock.jrj.com.cn/2022/01/28170134243241.shtml",
    "datetime": "2022-01-28 17:01:28",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：6654.3294万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/01/27222534234507.shtml",
    "datetime": "2022-01-27 22:25:55",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康近期减持732.54万股",
    "href": "http://stock.jrj.com.cn/2022/01/24195634206099.shtml",
    "datetime": "2022-01-24 19:56:15",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解除质押合计500万股",
    "href": "http://stock.jrj.com.cn/2022/01/18221334171572.shtml",
    "datetime": "2022-01-18 22:13:57",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解除质押300万股",
    "href": "http://stock.jrj.com.cn/2022/01/13202734155423.shtml",
    "datetime": "2022-01-13 20:27:22",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康自2021年12月29日起累计减持近1%股份",
    "href": "http://stock.jrj.com.cn/2022/01/12201834151201.shtml",
    "datetime": "2022-01-12 20:18:33",
    "code": "000403"
  },
  {
    "title": "派林生物：股东航运健康所持合计350万股解除质押",
    "href": "http://stock.jrj.com.cn/2022/01/07201134135006.shtml",
    "datetime": "2022-01-07 20:11:55",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解质350万股",
    "href": "http://stock.jrj.com.cn/2022/01/07194734134732.shtml",
    "datetime": "2022-01-07 19:47:46",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解质450万股",
    "href": "http://stock.jrj.com.cn/2021/12/29193434082528.shtml",
    "datetime": "2021-12-29 19:34:26",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康已减持0.99%的股份",
    "href": "http://stock.jrj.com.cn/2021/12/29193234082527.shtml",
    "datetime": "2021-12-29 19:32:54",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解质200万股",
    "href": "http://stock.jrj.com.cn/2021/12/20193834035841.shtml",
    "datetime": "2021-12-20 19:38:41",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：增持期过半 部分董监高及核心员工已合计增持25.98万股",
    "href": "http://stock.jrj.com.cn/2021/12/09203233991373.shtml",
    "datetime": "2021-12-09 20:32:17",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解除质押200万股",
    "href": "http://stock.jrj.com.cn/2021/12/08214333986366.shtml",
    "datetime": "2021-12-08 21:43:25",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：股东航运健康解质200万股",
    "href": "http://stock.jrj.com.cn/2021/12/02191233956466.shtml",
    "datetime": "2021-12-02 19:12:07",
    "code": "000403"
  },
  {
    "title": "派林生物：持股5%以上股东航运健康拟减持6171.72万股公司股份",
    "href": "http://stock.jrj.com.cn/2021/11/11202733837758.shtml",
    "datetime": "2021-11-11 20:27:07",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康拟清仓减持不超8.422%股份",
    "href": "http://stock.jrj.com.cn/2021/11/11194133837428.shtml",
    "datetime": "2021-11-11 19:41:11",
    "code": "000403"
  },
  {
    "title": "派林生物前三季净利润大增193% 研发投入没“掉队”",
    "href": "http://stock.jrj.com.cn/2021/10/21081633725619.shtml",
    "datetime": "2021-10-21 08:16:00",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SH)：前三季度净利润升192.88%至3.04亿元",
    "href": "http://stock.jrj.com.cn/2021/10/19192133717744.shtml",
    "datetime": "2021-10-19 19:21:47",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康已于10月1日-18日减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/10/19191933717742.shtml",
    "datetime": "2021-10-19 19:19:46",
    "code": "000403"
  },
  {
    "title": "A股异动 | 派林生物(000403.SZ)续涨4.3%，业绩预增叠加券商看好",
    "href": "http://stock.jrj.com.cn/2021/10/13110633683907.shtml",
    "datetime": "2021-10-13 11:06:18",
    "code": "000403"
  },
  {
    "title": "派林生物三季度净利润1.23亿元至1.35亿元 同比增长200%- 230%",
    "href": "http://stock.jrj.com.cn/2021/10/11100333671593.shtml",
    "datetime": "2021-10-11 10:03:57",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：预计前三季度盈利2.91亿元-3.22亿元 同比增长180.00%-210.00%",
    "href": "http://stock.jrj.com.cn/2021/10/11084733670924.shtml",
    "datetime": "2021-10-11 08:47:01",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康累计减持公司3%股份",
    "href": "http://stock.jrj.com.cn/2021/10/07224433649131.shtml",
    "datetime": "2021-10-07 22:44:26",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解质290.749万股",
    "href": "http://stock.jrj.com.cn/2021/09/22211133500365.shtml",
    "datetime": "2021-09-22 21:11:10",
    "code": "000403"
  },
  {
    "title": "派林生物：股东航运健康所持290.75万股解除质押",
    "href": "http://stock.jrj.com.cn/2021/09/22195933500294.shtml",
    "datetime": "2021-09-22 19:59:15",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：部分董监高及核心员工已合计增持25.98万股",
    "href": "http://stock.jrj.com.cn/2021/09/14190733435058.shtml",
    "datetime": "2021-09-14 19:07:44",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康再次减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/13191033429543.shtml",
    "datetime": "2021-09-13 19:10:26",
    "code": "000403"
  },
  {
    "title": "派林生物部分董监高及核心员工拟耗资不超1210万增持公司股份 上半年公司净利1.76亿",
    "href": "http://stock.jrj.com.cn/2021/09/09200433411015.shtml",
    "datetime": "2021-09-09 20:04:40",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：部分董监高及核心员工拟合计增持705万-1210万元股份",
    "href": "http://stock.jrj.com.cn/2021/09/09173833410244.shtml",
    "datetime": "2021-09-09 17:38:16",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康解除质押576.271万股",
    "href": "http://stock.jrj.com.cn/2021/09/08200833405703.shtml",
    "datetime": "2021-09-08 20:08:54",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：减持期过半 航运健康已减持1.73859%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/06191333393642.shtml",
    "datetime": "2021-09-06 19:13:29",
    "code": "000403"
  },
  {
    "title": "派林生物：股东航运健康所持240.44万股解除质押",
    "href": "http://stock.jrj.com.cn/2021/08/31195233363539.shtml",
    "datetime": "2021-08-31 19:52:50",
    "code": "000403"
  },
  {
    "title": "派林生物2021年半年度净利1.76亿元 同比净利增加179.56%",
    "href": "http://stock.jrj.com.cn/2021/08/27211533336011.shtml",
    "datetime": "2021-08-27 21:15:23",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)上半年净利升179.56%至1.76亿元",
    "href": "http://stock.jrj.com.cn/2021/08/27200733335562.shtml",
    "datetime": "2021-08-27 20:07:49",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：4800.48万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/08/18181533274927.shtml",
    "datetime": "2021-08-18 18:15:55",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：控股股东合伙企业架构拟发生变动",
    "href": "http://stock.jrj.com.cn/2021/08/13190833250113.shtml",
    "datetime": "2021-08-13 19:08:47",
    "code": "000403"
  },
  {
    "title": "派林生物2021年上半年预计净利1.7亿–1.89亿增长170%-200% 原料血浆供应明显增长",
    "href": "http://stock.jrj.com.cn/2021/07/14230033097341.shtml",
    "datetime": "2021-07-14 23:00:57",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)半年度净利预增170%-200%",
    "href": "http://stock.jrj.com.cn/2021/07/14215333096879.shtml",
    "datetime": "2021-07-14 21:53:00",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：可行权的股票期权为88.6305万份",
    "href": "http://stock.jrj.com.cn/2021/06/15000632929117.shtml",
    "datetime": "2021-06-15 00:06:17",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：88.8808万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2021/06/10211432907054.shtml",
    "datetime": "2021-06-10 21:14:00",
    "code": "000403"
  },
  {
    "title": "27亿商誉压顶二股东拟“清仓” 派林生物追赶“第一梯队”为何艰难？",
    "href": "http://stock.jrj.com.cn/2021/05/28065932832983.shtml",
    "datetime": "2021-05-28 06:59:15",
    "code": "000403"
  },
  {
    "title": "股民懵了 大股东清仓式减持35亿浮盈超10亿 一度大跌超7%",
    "href": "http://stock.jrj.com.cn/2021/05/13130232747680.shtml",
    "datetime": "2021-05-13 13:02:38",
    "code": "000403"
  },
  {
    "title": "A股异动 | 派林生物(000403.SZ)跌6.8% 持股12.5%股东航运健康拟清仓式减持",
    "href": "http://stock.jrj.com.cn/2021/05/13093832746560.shtml",
    "datetime": "2021-05-13 09:38:57",
    "code": "000403"
  },
  {
    "title": "派林生物：股东拟减持12.5%公司股份",
    "href": "http://stock.jrj.com.cn/2021/05/12201932743818.shtml",
    "datetime": "2021-05-12 20:19:03",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：航运健康拟清仓减持12.5%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/12201532743799.shtml",
    "datetime": "2021-05-12 20:15:11",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)：全资子公司获批设立博士工作站",
    "href": "http://stock.jrj.com.cn/2021/05/10194132731366.shtml",
    "datetime": "2021-05-10 19:41:06",
    "code": "000403"
  },
  {
    "title": "派林生物(000403)公布2021年一季报 净利润同比增长125.73%",
    "href": "http://stock.jrj.com.cn/2021/04/29175032481279.shtml",
    "datetime": "2021-04-29 17:50:44",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)一季度净利升125.73%至5640.17万元",
    "href": "http://stock.jrj.com.cn/2021/04/28233732474947.shtml",
    "datetime": "2021-04-28 23:37:57",
    "code": "000403"
  },
  {
    "title": "派林生物2020年净利增长15.9% 董事长黄灵谋薪酬286.78万",
    "href": "http://stock.jrj.com.cn/2021/04/20151032409647.shtml",
    "datetime": "2021-04-20 15:10:35",
    "code": "000403"
  },
  {
    "title": "A股异动 | 派林生物(000403.SZ)涨逾4% 一季度净利润预增120%-150%",
    "href": "http://stock.jrj.com.cn/2021/04/20104532408338.shtml",
    "datetime": "2021-04-20 10:45:20",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)2020年度净利润升15.9%至1.86亿元",
    "href": "http://stock.jrj.com.cn/2021/04/19212232404336.shtml",
    "datetime": "2021-04-19 21:22:33",
    "code": "000403"
  },
  {
    "title": "派林生物2021年第一季度预计净利增长120%-150% 销售价格上涨",
    "href": "http://stock.jrj.com.cn/2021/04/16194832388374.shtml",
    "datetime": "2021-04-16 19:48:34",
    "code": "000403"
  },
  {
    "title": "派林生物(000403.SZ)一季度净利润预增120%-150%",
    "href": "http://stock.jrj.com.cn/2021/04/14191032373135.shtml",
    "datetime": "2021-04-14 19:10:33",
    "code": "000403"
  },
  {
    "title": "双林生物2020年度净利1.87亿增长16.34% 产品销售实现较好增长",
    "href": "http://stock.jrj.com.cn/2021/03/24064632205230.shtml",
    "datetime": "2021-03-24 06:46:30",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)业绩快报：2020年度归母净利润升16.34%至1.87亿元",
    "href": "http://stock.jrj.com.cn/2021/03/23191932203216.shtml",
    "datetime": "2021-03-23 19:19:59",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：拟使用额度不超14.8亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/03/17201032152839.shtml",
    "datetime": "2021-03-17 20:10:48",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：与中国信达深圳市分公司签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2021/03/17200932152838.shtml",
    "datetime": "2021-03-17 20:09:40",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：证券简称拟变更为\"派林生物\"",
    "href": "http://stock.jrj.com.cn/2021/03/08194732092689.shtml",
    "datetime": "2021-03-08 19:47:55",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：公司名称拟变更为“派斯双林生物制药股份有限公司”",
    "href": "http://stock.jrj.com.cn/2021/03/01170232050968.shtml",
    "datetime": "2021-03-01 17:02:24",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)披露募集配套资金情况：易方达、中欧基金及李淑婷等参投",
    "href": "http://stock.jrj.com.cn/2021/02/21161131999219.shtml",
    "datetime": "2021-02-21 16:11:19",
    "code": "000403"
  },
  {
    "title": "【龙虎榜】双林生物2月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/02/18180431987649.shtml",
    "datetime": "2021-02-18 18:04:01",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：航运健康解除质押976.6万股及重新质押1176.6万股",
    "href": "http://stock.jrj.com.cn/2021/02/05174231855361.shtml",
    "datetime": "2021-02-05 17:42:20",
    "code": "000403"
  },
  {
    "title": "双林生物股东航运健康质押516.5万股 用于融资",
    "href": "http://stock.jrj.com.cn/2021/02/01192331831668.shtml",
    "datetime": "2021-02-01 19:23:03",
    "code": "000403"
  },
  {
    "title": "双林生物股东航运健康质押1549.5万股 用于融资",
    "href": "http://stock.jrj.com.cn/2021/01/25213831768959.shtml",
    "datetime": "2021-01-25 21:38:43",
    "code": "000403"
  },
  {
    "title": "[双林生物]喜讯!双林生物再次获得高新技术企业认定暨省级工程中心获“优秀”评级",
    "href": "http://stock.jrj.com.cn/2021/01/25000031771219.shtml",
    "datetime": "2021-01-25 00:00:00",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：过户完成 公司直接和间接合计持派斯菲科100%股权",
    "href": "http://stock.jrj.com.cn/2021/01/20183431730444.shtml",
    "datetime": "2021-01-20 18:34:17",
    "code": "000403"
  },
  {
    "title": "[双林生物]【喜报】双林生物获得“广东省文明单位”称号!",
    "href": "http://stock.jrj.com.cn/2021/01/04000031628340.shtml",
    "datetime": "2021-01-04 00:00:00",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：董事会通过关于新疆德源申请6000万元流动资金的议案",
    "href": "http://stock.jrj.com.cn/2021/01/03181231622194.shtml",
    "datetime": "2021-01-03 18:12:15",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：资产重组事项获中证监核准批文",
    "href": "http://stock.jrj.com.cn/2020/12/17203631511675.shtml",
    "datetime": "2020-12-17 20:36:58",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：控股股东及其一致行动人合计解押1.47亿股 浙民投天弘重新质押1.02亿股",
    "href": "http://stock.jrj.com.cn/2020/12/14194831488920.shtml",
    "datetime": "2020-12-14 19:48:43",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：航运健康解除质押2808万股并重新质押3250万股",
    "href": "http://stock.jrj.com.cn/2020/12/08203631442805.shtml",
    "datetime": "2020-12-08 20:36:41",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：约5.6万股限售股12月11日解禁",
    "href": "http://stock.jrj.com.cn/2020/12/08203531442802.shtml",
    "datetime": "2020-12-08 20:35:33",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)签订战略合作协议 拟向合作浆站和新疆德源采购血浆",
    "href": "http://stock.jrj.com.cn/2020/11/30210831378413.shtml",
    "datetime": "2020-11-30 21:08:43",
    "code": "000403"
  },
  {
    "title": "[双林生物]喜讯!双林生物、派斯菲科重组事项获通过!",
    "href": "http://stock.jrj.com.cn/2020/11/27000031466179.shtml",
    "datetime": "2020-11-27 00:00:00",
    "code": "000403"
  },
  {
    "title": "[双林生物]同心筑梦,孕育奇迹!双林生物成功举办中国生殖免疫高峰论坛!",
    "href": "http://stock.jrj.com.cn/2020/11/27000031466178.shtml",
    "datetime": "2020-11-27 00:00:00",
    "code": "000403"
  },
  {
    "title": "【龙虎榜】双林生物11月26日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/11/26180231353797.shtml",
    "datetime": "2020-11-26 18:02:22",
    "code": "000403"
  },
  {
    "title": "双林生物跌停 易方达均衡成长为第八大流通股东",
    "href": "http://stock.jrj.com.cn/2020/11/26143831352740.shtml",
    "datetime": "2020-11-26 14:38:00",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：重组事项获有条件通过 11月26日复牌",
    "href": "http://stock.jrj.com.cn/2020/11/25221431348633.shtml",
    "datetime": "2020-11-25 22:14:51",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：重组事项11月25日上会 当天停牌",
    "href": "http://stock.jrj.com.cn/2020/11/19201431318318.shtml",
    "datetime": "2020-11-19 20:14:15",
    "code": "000403"
  },
  {
    "title": "双林生物(000403.SZ)：资产重组将于近日上会",
    "href": "http://stock.jrj.com.cn/2020/11/18200331310117.shtml",
    "datetime": "2020-11-18 20:03:27",
    "code": "000403"
  },
  {
    "title": "双林生物前三季度净利1.04亿减少18.50% 营业外支出增加",
    "href": "http://stock.jrj.com.cn/2020/10/27095131140196.shtml",
    "datetime": "2020-10-27 09:51:47",
    "code": "000403"
  },
  {
    "title": "[双林生物]逆行出征显英雄本色,万里拉浆展双林担当!",
    "href": "http://stock.jrj.com.cn/2020/10/09000031466176.shtml",
    "datetime": "2020-10-09 00:00:00",
    "code": "000403"
  },
  {
    "title": "[双林生物]期待!双林人凝血因子VIII首次亮相全国血友病大会!",
    "href": "http://stock.jrj.com.cn/2020/10/09000031466177.shtml",
    "datetime": "2020-10-09 00:00:00",
    "code": "000403"
  },
  {
    "title": "[双林生物]【喜报】双林生物获得人凝血因子Ⅷ药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/09/10000031466174.shtml",
    "datetime": "2020-09-10 00:00:00",
    "code": "000403"
  },
  {
    "title": "[双林生物]【大事记】 双林销售系统重磅上线!",
    "href": "http://stock.jrj.com.cn/2020/09/10000031466175.shtml",
    "datetime": "2020-09-10 00:00:00",
    "code": "000403"
  },
  {
    "title": "双林生物2020年上半年净利6294.03万下滑18.85% 受国家产业政策和医疗改革影响",
    "href": "http://stock.jrj.com.cn/2020/08/28220830616989.shtml",
    "datetime": "2020-08-28 22:08:27",
    "code": "000403"
  },
  {
    "title": "双林生物31亿元收购派斯菲科遭问询 溢价近6倍",
    "href": "http://stock.jrj.com.cn/2020/07/09160830192417.shtml",
    "datetime": "2020-07-09 16:08:00",
    "code": "000403"
  },
  {
    "title": "快讯：双林生物急速拉升7.17% 主力资金净流入808.00万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/02101230119633.shtml",
    "datetime": "2020-07-02 10:12:23",
    "code": "000403"
  },
  {
    "title": "双林生物签订供浆合作协议 提高血液制品业务综合竞争力",
    "href": "http://stock.jrj.com.cn/invest/2020/06/24085030007793.shtml",
    "datetime": "2020-06-24 08:50:00",
    "code": "000403"
  },
  {
    "title": "双林生物拟收购派斯菲科并引入战投 采浆量有望突破1000吨成血液制品巨头",
    "href": "http://stock.jrj.com.cn/2020/05/25091429757285.shtml",
    "datetime": "2020-05-25 09:14:54",
    "code": "000403"
  },
  {
    "title": "【龙虎榜】双林生物5月20日成交明细(dev)",
    "href": "http://stock.jrj.com.cn/2020/05/20180129723031.shtml",
    "datetime": "2020-05-20 18:01:52",
    "code": "000403"
  },
  {
    "title": "美国生物技术公司公布新冠疫苗研发进展 北大医药、双林生物等今日涨停 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/05/19190529713662.shtml",
    "datetime": "2020-05-19 19:05:37",
    "code": "000403"
  },
  {
    "title": "拟收购血制品企业派斯菲科100%股权 双林生物连续3日涨停",
    "href": "http://stock.jrj.com.cn/2020/05/19093829709340.shtml",
    "datetime": "2020-05-19 09:38:47",
    "code": "000403"
  },
  {
    "title": "拟收购血制品企业派斯菲科100%股权 双林生物连续两日涨停",
    "href": "http://stock.jrj.com.cn/2020/05/18100829700218.shtml",
    "datetime": "2020-05-18 10:08:45",
    "code": "000403"
  },
  {
    "title": "拟收购血制品企业派斯菲科100%股权 双林生物复牌涨停",
    "href": "http://stock.jrj.com.cn/2020/05/15104829679121.shtml",
    "datetime": "2020-05-15 10:48:04",
    "code": "000403"
  },
  {
    "title": "双林生物拟发行股份购买资产 引入战略投资者保障公司持续稳定发展",
    "href": "http://stock.jrj.com.cn/invest/2020/05/15093929679127.shtml",
    "datetime": "2020-05-15 09:39:00",
    "code": "000403"
  },
  {
    "title": "双林生物拟发行股份购买资产 引入战略投资者保障公司持续稳定发展",
    "href": "http://stock.jrj.com.cn/invest/2020/05/15093929734101.shtml",
    "datetime": "2020-05-15 09:39:00",
    "code": "000403"
  },
  {
    "title": "双林生物：关于披露重组预案暨公司股票复牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2020/05/14235029674611.shtml",
    "datetime": "2020-05-14 23:50:00",
    "code": "000403"
  },
  {
    "title": "双林生物2019年净利1.6亿增长100.60% 董事长薪酬287.1万",
    "href": "http://stock.jrj.com.cn/2020/05/03160429499811.shtml",
    "datetime": "2020-05-03 16:04:00",
    "code": "000403"
  },
  {
    "title": "双林生物2020年一季度盈利2498.67万元 同比增长3%",
    "href": "http://stock.jrj.com.cn/2020/05/01195329441096.shtml",
    "datetime": "2020-05-01 19:53:02",
    "code": "000403"
  },
  {
    "title": "双林生物董事郑毅辞职 因个人原因",
    "href": "http://stock.jrj.com.cn/2020/04/01200029170796.shtml",
    "datetime": "2020-04-01 20:00:33",
    "code": "000403"
  },
  {
    "title": "双林生物2019年度盈利1.64亿增长105% 调整产品销售策略",
    "href": "http://stock.jrj.com.cn/2020/03/17222029047586.shtml",
    "datetime": "2020-03-17 22:20:27",
    "code": "000403"
  },
  {
    "title": "双林生物业绩快报：2019年净利同比增长105%",
    "href": "http://stock.jrj.com.cn/2020/03/17204629047062.shtml",
    "datetime": "2020-03-17 20:46:11",
    "code": "000403"
  },
  {
    "title": "双林生物业绩快报：2019年净利同比增104%",
    "href": "http://stock.jrj.com.cn/2020/03/17192729046637.shtml",
    "datetime": "2020-03-17 19:27:00",
    "code": "000403"
  },
  {
    "title": "双林生物：2019年净利1.64亿元 同比增长105%",
    "href": "http://stock.jrj.com.cn/2020/03/17192529046601.shtml",
    "datetime": "2020-03-17 19:25:32",
    "code": "000403"
  },
  {
    "title": "[双林生物]同舟共济,共抗疫情,双林生物在行动!",
    "href": "http://stock.jrj.com.cn/2020/02/20000031466169.shtml",
    "datetime": "2020-02-20 00:00:00",
    "code": "000403"
  },
  {
    "title": "双林生物为子公司最高10亿元融资综合授信额度提供连带责任保证",
    "href": "http://stock.jrj.com.cn/2020/02/17204328841039.shtml",
    "datetime": "2020-02-17 20:43:27",
    "code": "000403"
  },
  {
    "title": "双林生物累计向抗“疫”一线提供静丙约20万支",
    "href": "http://stock.jrj.com.cn/2020/02/16193728835189.shtml",
    "datetime": "2020-02-16 19:37:50",
    "code": "000403"
  },
  {
    "title": "双林生物第二批捐赠药资230.1万元",
    "href": "http://stock.jrj.com.cn/2020/02/14215528831641.shtml",
    "datetime": "2020-02-14 21:55:47",
    "code": "000403"
  },
  {
    "title": "双林生物第二批捐赠药资已送达",
    "href": "http://stock.jrj.com.cn/2020/02/14214828831604.shtml",
    "datetime": "2020-02-14 21:48:00",
    "code": "000403"
  },
  {
    "title": "双林生物捐赠价值59万元药品",
    "href": "http://stock.jrj.com.cn/2020/01/29185728741556.shtml",
    "datetime": "2020-01-29 18:57:17",
    "code": "000403"
  },
  {
    "title": "双林生物捐赠自产药品驰援抗疫阵地",
    "href": "http://stock.jrj.com.cn/2020/01/29181128741447.shtml",
    "datetime": "2020-01-29 18:11:00",
    "code": "000403"
  },
  {
    "title": "双林生物业绩预增九成 控股股东股份全部质押 高增长能否持续？",
    "href": "http://stock.jrj.com.cn/2020/01/16071028684364.shtml",
    "datetime": "2020-01-16 07:10:00",
    "code": "000403"
  },
  {
    "title": "双林生物：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/15233028683314.shtml",
    "datetime": "2020-01-15 23:30:04",
    "code": "000403"
  },
  {
    "title": "双林生物：2019年净利同比预增90%-120%",
    "href": "http://stock.jrj.com.cn/2020/01/15215528682853.shtml",
    "datetime": "2020-01-15 21:55:38",
    "code": "000403"
  },
  {
    "title": "双林生物推动经营变革 预计2019年盈利1.52亿元以上同比增长超90%",
    "href": "http://stock.jrj.com.cn/2020/01/15214728682829.shtml",
    "datetime": "2020-01-15 21:47:52",
    "code": "000403"
  },
  {
    "title": "双林生物：预计2019年净利同比增90%-120%",
    "href": "http://stock.jrj.com.cn/2020/01/15210828682701.shtml",
    "datetime": "2020-01-15 21:08:00",
    "code": "000403"
  },
  {
    "title": "双林生物核销其他应收款1.7亿元 控股股东所持股份已全部质押",
    "href": "http://stock.jrj.com.cn/2019/12/30085328602100.shtml",
    "datetime": "2019-12-30 08:53:00",
    "code": "000403"
  },
  {
    "title": "双林生物核销其他应收款1.7亿元 控股股东所持股份已全部质押",
    "href": "http://stock.jrj.com.cn/2019/12/30084228601711.shtml",
    "datetime": "2019-12-30 08:42:00",
    "code": "000403"
  },
  {
    "title": "双林生物拟核销1.72亿其他应收账款：多次追讨无法收回 前三季度净利润1.27亿元",
    "href": "http://stock.jrj.com.cn/2019/12/29180928599873.shtml",
    "datetime": "2019-12-29 18:09:41",
    "code": "000403"
  },
  {
    "title": "双林生物：正积极洽谈增设新浆站 优化调整特免类产品销售模式",
    "href": "http://stock.jrj.com.cn/2019/11/26164028453250.shtml",
    "datetime": "2019-11-26 16:40:14",
    "code": "000403"
  },
  {
    "title": "振兴生化：正式更名为“双林生物” 公司发展进入崭新阶段",
    "href": "http://stock.jrj.com.cn/2019/11/19114028417920.shtml",
    "datetime": "2019-11-19 11:40:45",
    "code": "000403"
  },
  {
    "title": "[双林生物]新时代,新征程——母公司振兴生化完成名称变更",
    "href": "http://stock.jrj.com.cn/2019/11/19000031465280.shtml",
    "datetime": "2019-11-19 00:00:00",
    "code": "000403"
  },
  {
    "title": "振兴生化11月19日起更名为双林生物",
    "href": "http://stock.jrj.com.cn/2019/11/18195028414508.shtml",
    "datetime": "2019-11-18 19:50:54",
    "code": "000403"
  },
  {
    "title": "振兴生化：11月19日起简称变更为“双林生物”",
    "href": "http://stock.jrj.com.cn/2019/11/18174728413627.shtml",
    "datetime": "2019-11-18 17:47:00",
    "code": "000403"
  },
  {
    "title": "振兴生化：子公司获人纤维蛋白粘合剂药物临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/11/14215228401322.shtml",
    "datetime": "2019-11-14 21:52:21",
    "code": "000403"
  },
  {
    "title": "振兴生化：前三季度净利1.27亿元 同比增长58%",
    "href": "http://stock.jrj.com.cn/2019/10/18204328269486.shtml",
    "datetime": "2019-10-18 20:43:26",
    "code": "000403"
  },
  {
    "title": "振兴生化：前三季度净利同比增58% 拟更名为“双林生物”",
    "href": "http://stock.jrj.com.cn/2019/10/18192328269251.shtml",
    "datetime": "2019-10-18 19:23:00",
    "code": "000403"
  },
  {
    "title": "振兴生化2019年前三季度净利约1.21亿元–1.33亿元 公司经营费用降低",
    "href": "http://stock.jrj.com.cn/2019/10/12134928236985.shtml",
    "datetime": "2019-10-12 13:49:51",
    "code": "000403"
  },
  {
    "title": "振兴生化前三季净利预增50%-65%",
    "href": "http://stock.jrj.com.cn/2019/10/11221128235483.shtml",
    "datetime": "2019-10-11 22:11:22",
    "code": "000403"
  },
  {
    "title": "振兴生化：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/11200028234968.shtml",
    "datetime": "2019-10-11 20:00:02",
    "code": "000403"
  },
  {
    "title": "[双林生物]“牢记使命,严把质量关”,广东省副省长、党组成员陈良贤率队考察广东双林",
    "href": "http://stock.jrj.com.cn/2019/08/24000031465282.shtml",
    "datetime": "2019-08-24 00:00:00",
    "code": "000403"
  },
  {
    "title": "振兴生化2019年上半年净利7756万 销售收款增加",
    "href": "http://stock.jrj.com.cn/2019/08/23175528024141.shtml",
    "datetime": "2019-08-23 17:55:02",
    "code": "000403"
  },
  {
    "title": "振兴生化：上半年净利7756万元 同比增16%",
    "href": "http://stock.jrj.com.cn/2019/07/24184527882813.shtml",
    "datetime": "2019-07-24 18:45:51",
    "code": "000403"
  },
  {
    "title": "振兴生化2019年上半年净利润7756万元 公司经营费用降低",
    "href": "http://stock.jrj.com.cn/2019/07/24184127882809.shtml",
    "datetime": "2019-07-24 18:41:57",
    "code": "000403"
  },
  {
    "title": "振兴生化：上半年净利7756万元 同比增长16%",
    "href": "http://stock.jrj.com.cn/2019/07/24183727882806.shtml",
    "datetime": "2019-07-24 18:37:00",
    "code": "000403"
  },
  {
    "title": "振兴生化：子公司湖南唯康破产管理人已指定",
    "href": "http://stock.jrj.com.cn/2019/05/16170127582131.shtml",
    "datetime": "2019-05-16 17:01:00",
    "code": "000403"
  },
  {
    "title": "振兴生化一季度净利2434万同比下滑14% 现金流量净额-1686万",
    "href": "http://stock.jrj.com.cn/2019/05/06062527526639.shtml",
    "datetime": "2019-05-06 06:25:01",
    "code": "000403"
  },
  {
    "title": "[双林生物]喜报|广东双林荣获“2019年广东省五一劳动奖状”",
    "href": "http://stock.jrj.com.cn/2019/05/05000031465281.shtml",
    "datetime": "2019-05-05 00:00:00",
    "code": "000403"
  },
  {
    "title": "振兴生化去年净利7998万同比增长270% 总经理罗军薪酬360.98万",
    "href": "http://stock.jrj.com.cn/2019/04/25183927483099.shtml",
    "datetime": "2019-04-25 18:39:52",
    "code": "000403"
  },
  {
    "title": "振兴生化股东振兴集团减持455万股 套现1.17亿元",
    "href": "http://stock.jrj.com.cn/2019/04/04073927318660.shtml",
    "datetime": "2019-04-04 07:39:00",
    "code": "000403"
  },
  {
    "title": "佳兆业回应对振兴生化未来计划：希望与浙民投能够更团结",
    "href": "http://stock.jrj.com.cn/2019/03/27050227245436.shtml",
    "datetime": "2019-03-27 05:02:00",
    "code": "000403"
  },
  {
    "title": "振兴生化：解除股份限售的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/03/13200027161242.shtml",
    "datetime": "2019-03-13 20:00:04",
    "code": "000403"
  },
  {
    "title": "振兴生化控制权之争落幕 股东各方达成一致",
    "href": "http://stock.jrj.com.cn/2019/03/07035627128709.shtml",
    "datetime": "2019-03-07 03:56:37",
    "code": "000403"
  },
  {
    "title": "浙民投：各方达成一致促进公司发展 振兴生化控制权争夺已结束",
    "href": "http://stock.jrj.com.cn/2019/03/06145227126466.shtml",
    "datetime": "2019-03-06 14:52:00",
    "code": "000403"
  },
  {
    "title": "原实控人取消诉讼 振兴生化二次控制权之争或落幕",
    "href": "http://stock.jrj.com.cn/2019/03/05165427124313.shtml",
    "datetime": "2019-03-05 16:54:00",
    "code": "000403"
  },
  {
    "title": "振兴生化股东航运健康质押5062万股 用于补充流动性资金",
    "href": "http://stock.jrj.com.cn/2019/02/18215627057020.shtml",
    "datetime": "2019-02-18 21:56:21",
    "code": "000403"
  },
  {
    "title": "浙民投增持振兴生化至30%",
    "href": "http://stock.jrj.com.cn/2019/02/02050627015042.shtml",
    "datetime": "2019-02-02 05:06:43",
    "code": "000403"
  },
  {
    "title": "浙民投增持稳固控制权 持股振兴生化比例至30%",
    "href": "http://stock.jrj.com.cn/2019/02/01105727012282.shtml",
    "datetime": "2019-02-01 10:57:00",
    "code": "000403"
  },
  {
    "title": "振兴生化控股股东浙民投天弘的一致行动人增持100股 耗资约2.57万元",
    "href": "http://stock.jrj.com.cn/2019/01/31225327009910.shtml",
    "datetime": "2019-01-31 22:53:50",
    "code": "000403"
  },
  {
    "title": "前实控人再度现身添变数 振兴生化宫斗未了局",
    "href": "http://stock.jrj.com.cn/2019/01/22052226938655.shtml",
    "datetime": "2019-01-22 05:22:55",
    "code": "000403"
  },
  {
    "title": "控制权争夺一波三折 振兴生化实控方与佳兆业关系微妙",
    "href": "http://stock.jrj.com.cn/2019/01/17014126916070.shtml",
    "datetime": "2019-01-17 01:41:20",
    "code": "000403"
  },
  {
    "title": "振兴生化原实控方振兴集团夺权失利 疑与佳兆业内讧",
    "href": "http://stock.jrj.com.cn/2019/01/16180326914527.shtml",
    "datetime": "2019-01-16 18:03:52",
    "code": "000403"
  },
  {
    "title": "振兴生化：2018年净利预增260%-385%",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/14080026899503.shtml",
    "datetime": "2019-01-14 08:00:01",
    "code": "000403"
  },
  {
    "title": "“佳兆业系”高管被曝协助调查 振兴生化“夺章”升级",
    "href": "http://stock.jrj.com.cn/2019/01/14031526898561.shtml",
    "datetime": "2019-01-14 03:15:51",
    "code": "000403"
  },
  {
    "title": "振兴生化内乱升级 监事会主席被协查",
    "href": "http://stock.jrj.com.cn/2019/01/14021926898435.shtml",
    "datetime": "2019-01-14 02:19:06",
    "code": "000403"
  },
  {
    "title": "振兴生化监事会主席已返回公司",
    "href": "http://stock.jrj.com.cn/2019/01/13114826896718.shtml",
    "datetime": "2019-01-13 11:48:17",
    "code": "000403"
  },
  {
    "title": "振兴生化：2018年度业绩预告",
    "href": "http://stock.jrj.com.cn/2019/01/11220026892312.shtml",
    "datetime": "2019-01-11 22:00:00",
    "code": "000403"
  },
  {
    "title": "振兴生化：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/11210026892028.shtml",
    "datetime": "2019-01-11 21:00:00",
    "code": "000403"
  },
  {
    "title": "振兴生化：2018年净利润预增260%-385%",
    "href": "http://stock.jrj.com.cn/2019/01/11203626891997.shtml",
    "datetime": "2019-01-11 20:36:48",
    "code": "000403"
  },
  {
    "title": "两大股东缠斗升级 振兴生化前途未卜",
    "href": "http://stock.jrj.com.cn/2018/12/25051626796722.shtml",
    "datetime": "2018-12-25 05:16:38",
    "code": "000403"
  },
  {
    "title": "[天眼]深交所关注振兴生化董事会内讧:是否有意限制股东权利",
    "href": "http://stock.jrj.com.cn/2018/12/21174126780243.shtml",
    "datetime": "2018-12-21 17:41:07",
    "code": "000403"
  },
  {
    "title": "争夺子公司控制权！振兴生化几大股东反目成仇",
    "href": "http://stock.jrj.com.cn/2018/12/20064426768281.shtml",
    "datetime": "2018-12-20 06:44:48",
    "code": "000403"
  },
  {
    "title": "振兴生化内战硝烟再起 浙民投罢免“佳兆业系”高管",
    "href": "http://stock.jrj.com.cn/2018/12/20042026767952.shtml",
    "datetime": "2018-12-20 04:20:03",
    "code": "000403"
  },
  {
    "title": "为争夺子公司控制权 振兴生化几大股东反目成仇",
    "href": "http://stock.jrj.com.cn/2018/12/19212126767030.shtml",
    "datetime": "2018-12-19 21:21:55",
    "code": "000403"
  },
  {
    "title": "“炮轰”佳兆业 浙民投发起全面夺权",
    "href": "http://stock.jrj.com.cn/2018/12/19025626762165.shtml",
    "datetime": "2018-12-19 02:56:36",
    "code": "000403"
  },
  {
    "title": "振兴生化董事会内讧 大股东提名董事遭举报",
    "href": "http://stock.jrj.com.cn/2018/12/18052926757095.shtml",
    "datetime": "2018-12-18 05:29:16",
    "code": "000403"
  },
  {
    "title": "ST生化：21日停牌1天 22日起更名为“振兴生化”",
    "href": "http://stock.jrj.com.cn/2018/11/20195725380951.shtml",
    "datetime": "2018-11-20 19:57:10",
    "code": "000403"
  },
  {
    "title": "ST生化：22日起撤销其他风险警示 简称变更为“振兴生化”",
    "href": "http://stock.jrj.com.cn/2018/11/20193225380897.shtml",
    "datetime": "2018-11-20 19:32:00",
    "code": "000403"
  },
  {
    "title": "[双林生物]捐献血浆,从我做起",
    "href": "http://stock.jrj.com.cn/2017/02/17000031465284.shtml",
    "datetime": "2017-02-17 00:00:00",
    "code": "000403"
  },
  {
    "title": "[双林生物]新年快乐,开工大吉!",
    "href": "http://stock.jrj.com.cn/2017/02/14000031465283.shtml",
    "datetime": "2017-02-14 00:00:00",
    "code": "000403"
  }
]